Background: Endovascular aneurysm repair (EVAR) is becoming the preferred treatment modality for patients with a ruptured abdominal aortic aneurysm (rAAA). Although the survival advantage of EVAR over open aortic repair (OAR) has been shown in some studies, it is unclear whether this benefit extends to elderly patients. We sought to evaluate the outcomes of rAAA repair in octogenarians.
Treatment of ruptured abdominal aortic aneurysm (rAAA) continues to be associated with significant mortality and morbidity despite recent advances in emergency response systems, anesthesia, critical care, and surgical techniques. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] Traditionally, open aortic repair (OAR) has been the treatment of choice for patients with rAAA. Recently, there has been increased adoption of endovascular aneurysm repair (EVAR), both in the general population and among elderly patients with suspected rAAA. 2, [6] [7] [8] [9] [10] [12] [13] [14] In some centers, EVAR has become the preferred approach because of the perceived survival benefit over OAR. 2, 8, 9, [14] [15] [16] Recently published randomized controlled trials and meta-analyses comparing EVAR with OAR for rAAA have, however, demonstrated no significant differences in short-and long-term postoperative survival. 1, 3, 4, [17] [18] [19] Quality of life and cost-effectiveness might be better with the endovascular approach. 4 A number of studies have shown the association between increased age and elevated risk of death and complications after AAA repair. 12, 13, [20] [21] [22] [23] In some series, advanced age has been used as a reason to declare elderly patients "unfit for surgery." 13 It is also unclear whether traditional open surgery or the less invasive endovascular approach is the optimal method for emergent repair of rAAA in the elderly population. 20, [23] [24] [25] [26] [27] [28] [29] [30] Despite the lack of clear evidence, there is continuing adoption of endovascular surgery in older patients undergoing emergent repair. 23, 31 Some small series reported comparable and acceptable outcomes after repair of rAAA in octogenarians compared with their younger counterparts. 23, 32 The aim of this study was to use a large national surgical database to examine treatment trends and to 
METHODS
Elderly patients who underwent surgical repair for rAAA were identified from the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) database. This nationally validated, riskadjusted, and outcomes-based program developed by the ACS is used to measure and to improve the quality of surgical care in the United States (http://site.acsnsqip. org). In 2015, there were >700 academic and community hospitals participating in the ACS NSQIP. A dedicated surgical clinical reviewer at each participating hospital is trained to collect preoperative and 30-day postoperative data, and >135 patient variables are collected. 33 Collected data from each participating site are regularly audited to ensure the accuracy of the program. 33 The use of the ACS NSQIP database for this study was reviewed and approved by our local Institutional Review Board as an exempted study. Informed consent was not required for the study. The 2005 to 2014 ACS NSQIP Participant Use Data Files were used to identify our study cohort. Elderly patients, defined by age older than 80 years, who underwent surgical repair for rAAA were identified by the International Classification of Diseases, Ninth Revision diagnosis code 441.3 (abdominal aneurysmdruptured). Open surgery for rAAA was identified by Current Procedural Terminology (CPT) codes 35081, 35082, 35102, and 35103; EVAR was identified with the CPT codes 34800, 34802, 34803, 34804, 34805, and 34825. Patients were stratified into two groups based on the modality of treatment (EVAR vs OAR). Preoperative demographics (age, gender, race) and medical comorbidities as well as intraoperative information were reviewed. Perioperative outcomes included 30-day mortality, inhospital mortality, reoperation, postoperative infective complications (surgical site infection, pneumonia, urinary tract infection), thromboembolism (deep venous thrombosis and pulmonary embolism), cardiac event (myocardial infarction and cardiac arrest requiring cardiopulmonary resuscitation), respiratory complication (unplanned intubation and need for ventilator >48 hours), renal failure, stroke, and blood transfusion requirement. Overall hospital length of stay (LOS) was also evaluated.
Perioperative outcomes of EVAR and OAR cohorts were compared, and procedural trends were evaluated during the study period (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) . Bivariate analysis was performed using the c 2 test for categorical variables and the Student t-test for continuous variables. Hospital LOS was compared using gamma regression testing. Multivariable analyses were performed using logistic regression for binary outcomes (30-day mortality, pneumonia, ventilator >48 hours) and gamma regression for LOS. Factors included in multivariable analyses were age, gender, smoking, diabetes, cardiac disease, anesthesia, and American Society of Anesthesiologists (ASA) classification. The association was expressed as adjusted odds ratio (AOR) for logistic regression and adjusted mean ratio for gamma regression with corresponding 95% confidence interval (CI). Analyses were performed using SAS 9.3 software (SAS Institute, Cary, NC), and P value < .5 was considered to be significant.
RESULTS
There were 1048 elderly patients who underwent surgical repair for rAAA in this study, including 450 EVAR (43%) and 598 OAR (57%) procedures. The mean age was 83.7 years; 70% of the patients were male, and >88% were white. More than 88% of the patients were functionally independent, and the majority were classified as ASA class 4 or 5. Most procedures (96%) were performed by a vascular surgeon, and >60% required perioperative blood transfusion. Approximately 3% of patients had a standing "do not resuscitate" code status reversed before surgical repair (Table I) .
Age, gender, functional status, and medical comorbidities including cardiac and pulmonary disease were closely matched between the two cohorts. Patients who underwent OAR were more likely to have the procedure performed under general anesthesia (100% vs 89%; P < .001) and to be classified as ASA class 4 or 5 (94% vs 86%; P < .001). Although overall anesthesia time was similar, patients who underwent OAR had longer operation times compared with EVAR. Overall, >90% of EVAR and OAR was performed by a vascular surgeon, and endovascular repair for rAAA was more likely to be performed by a vascular surgeon (98% vs 93%; P < .001; Table I ).
The overall 30-day mortality for this elderly population was 41%, and the most common morbidities were pneumonia (16%), acute renal failure (13%), and septic shock ARTICLE HIGHLIGHTS Take Home Message: Thirty-day mortality of ruptured abdominal aortic aneurysm in 1048 patients older than 80 years was 33% after endovascular aneurysm repair and 47% after open repair (P < .001). Open repair predicted higher mortality.
The authors suggest endovascular aneurysm repair for ruptured abdominal aortic aneurysm in octogenarians when it is anatomically feasible.
(11%). Up to 34% of patients required ventilator support for >48 hours, and 17% required reoperation (Table II) . On bivariate analysis, patients who underwent OAR had significantly higher in-hospital and 30-day mortality. Postoperative pulmonary complications including pneumonia, unplanned intubation, and ventilator requirement for >48 hours were also significantly higher in the OAR cohort. Operative time and hospital LOS were longer for patients who underwent OAR (Table II) . On multivariable analysis, patients who underwent OAR had a significantly higher risk of 30-day mortality (AOR, 1.6; 95% CI, 1.3-2.2; P < .001), pneumonia (AOR, 2.5; 95% CI, 1.9-3.3; P < .001), and >48 hour ventilator dependence (AOR, 2.5; 95% CI, 1.8-3.3; P < .001; Fig 1) . Other factors associated with 30-day mortality were general anesthesia (AOR, 2.6; 95% CI, 1.2-6.0; P ¼ .02) and ASA classification (AOR, 2.1; 95% CI, 1.3-3.5; P ¼ .003). Total LOS was significantly longer for OAR (adjusted mean ratio, 1.4; 95% CI, 1.2-1.6; P < .001). The use of EVAR in the treatment of rAAA has increased between 2005 and 2014 (Fig 2) . In 2011, EVAR replaced OAR as the most common approach for the treatment of rAAA in this study population.
DISCUSSION
We believe this to be one of the largest studies evaluating the outcomes of emergent surgery in elderly patients with rAAA. Treatment of rAAA in this relatively high risk population is challenging, with overall 30-day mortality noted to exceed 40%. In this series, the majority of EVAR and OAR was performed by vascular surgeons, and there was increased adoption of the use of EVAR to treat rAAA. Elderly patients seemed to do better overall with the less invasive endovascular approach in our analysis. Those who underwent OAR had significantly higher risk of perioperative mortality and pulmonary complications, including pneumonia, longer ventilator requirement, and reintubation, compared with those who underwent EVAR. Hospital resource use, including operative time and hospital LOS, was also significantly higher in the OAR cohort.
Significant numbers of elderly patients with rAAA were deemed unfit for surgery and hence were not offered the option of surgical repair. 13 The mortality rate of patients with rAAA who did not undergo surgical repair was 100%. 13, 34 Advanced age has been identified as one of the significant risk factors for death after surgery for patients with rAAA. 35, 36 In a recent study by Park et al, who used the Nationwide Inpatient Sample to evaluate the trends in the treatment of rAAA, up to 22% of patients were not offered surgical treatment, and age played a substantial role in that decision. 13 Patients who exceeded 80 years of age were significantly less likely to be treated compared with their younger counterparts. 13 Short-term mortality after OAR and EVAR for rAAA in the general population is reported to be 35% to 48% recent randomized trials showed a nonsignificant trend for lower mortality for the endovascular strategy. 18 The quality of life was found to be higher and costs were lower for the survival of an endovascular strategy at 12 months. 4 Although there was some benefit with the endovascular approach, current evidence does not warrant widespread adoption of EVAR for rAAA. It is unclear as to which surgical approach for rAAA is best in elderly patients. A recent study by Edwards et al compared the effectiveness of EVAR and OAR for rAAA among Medicare beneficiaries and noted EVAR to be associated with a survival benefit that persisted for >4 years in patients aged 80 to 84 years and those older than 85 years. 9 Others have also shown a survival benefit for EVAR in patients aged >75 years and octogenarians. 23, 36 We have similarly found that EVAR is associated with better perioperative survival in elderly patients compared with traditional OAR. Pulmonary complications including pneumonia, need for reintubation, and need for longer ventilator support were also significantly higher after OAR. Operating time and overall hospital LOS were found to be significantly shorter with EVAR in this population of patients. The endovascular approach for emergent repair of rAAA has gained acceptance during the last decade. Traditionally, OAR is the treatment of choice for patients presenting with suspected rAAA. There were, however, increases in the use of EVAR to treat rAAA in recent years. 2, [7] [8] [9] [10] 15, 38 In some studies, EVAR had replaced OAR to become the most common approach to treatment of rAAA. 2, 7, 38 Similar trends were also observed in elderly patients in this study. There was significant increase in EVAR, and the endovascular approach had replaced OAR to become the most common method to treat rAAA in elderly patients toward the later part of this study period. Around 3% of elderly patients had their "do not resuscitate" code status reversed and underwent surgical repair in this study. However, it is unclear whether these patients had a prior diagnosis of AAA or, with undiagnosed AAA, presented initially after rupture. We were also unable to determine the exact reason for their code status. Surgeons should spend time discussing code status and the decision for emergent surgical repair in the event of rAAA in the office when surveillance is in progress.
Our study has a number of important limitations. It is observational and, as such, uses a retrospectively collected database to compare the outcomes of elderly patients who underwent surgical repair for rAAA. The study is limited by the variables that were collected in the ACS NSQIP database, and it is likely that our analysis did not account for all potential confounders. Second, we were not able to evaluate the hemodynamic status on presentation and the status of hospital transfer because of the inherent limitation of the ACS NSQIP data set. It was also not possible to evaluate aneurysm Unplanned intubation 124 (12) 82 (14) 42 (9) .03
Ventilator dependence >48 hours 355 (34) 259 (43) 96 (21) <.001
Pulmonary embolism 12 (1) 6 (1) 6 (1) .62
Progressive renal insufficiency 66 (6) 49 (8) 17 (4) .004
Acute renal failure 138 (13) 81 (14) 57 (13) .68
Urinary tract infection 66 (6) 45 (8) 21 (5) .06
CVA with neurologic deficit 11 (1) 6 (1) 5 (1) .87
Cardiac arrest requiring CPR 97 (9) 58 (10) 39 (9) .57
Myocardial infarction 61 (6) 34 (6) 27 (6) . Even with these limitations, we were able to use the ACS NSQIP data set to study a large cohort of elderly patients who underwent surgical repair of rAAA. This riskadjusted data set has been used successfully by others to study the outcomes of patients after surgical repair of rAAA. 6, 7, 10, 38 In one of the largest studies evaluating the outcomes after surgical repair of rAAA in elderly patients, we noted significantly better short-term survival and lower risk of pulmonary complications after EVAR compared with OAR. There was also a decrease in hospital resource use, which included shorter procedure time and LOS with the endovascular approach. This finding might be the reason for increased adoption of EVAR for rAAA in hospitals participating in the NSQIP for this high-risk population.
CONCLUSIONS
Elderly patients have significant perioperative mortality after surgical repair of rAAA, but it is comparable with that of the general population. Advanced age should not be used as the sole reason to turn down elderly patients in need of rAAA repair. The use of endovascular repair is increasing in the elderly population and can be associated with better short-term survival. Perioperative morbidities, especially pulmonary complications, were also significantly lower with EVAR. Further studies are needed to clearly delineate the best therapeutic options in these patients.
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